Glycolysis: Difference between revisions

Jump to navigation Jump to search
imported>OAbot
m Open access bot: pmc updated in citation with #oabot.
 
imported>Artoria2e5
 
Line 5: Line 5:
[[File:Glycolysis Summary.svg|thumb|375x375px|Summary of the 10 reactions of the glycolysis pathway]]
[[File:Glycolysis Summary.svg|thumb|375x375px|Summary of the 10 reactions of the glycolysis pathway]]


The wide occurrence of glycolysis in other species indicates that it is an ancient metabolic pathway.<ref>{{cite journal | vauthors = Romano AH, Conway T | title = Evolution of carbohydrate metabolic pathways | journal = Research in Microbiology | volume = 147 | issue = 6–7 | pages = 448–455 | year = 1996 | pmid = 9084754 | doi = 10.1016/0923-2508(96)83998-2 | doi-access = free }}</ref> Indeed, the reactions that make up glycolysis and its parallel pathway, the [[pentose phosphate pathway]], can occur in the [[Great Oxygenation Event|oxygen-free conditions]] of the [[Archean]] oceans, also in the absence of enzymes, catalyzed by metal ions, meaning this is a plausible prebiotic pathway for [[abiogenesis]].<ref>{{cite journal | vauthors = Keller MA, Turchyn AV, Ralser M | title = Non-enzymatic glycolysis and pentose phosphate pathway-like reactions in a plausible Archean ocean | journal = Molecular Systems Biology | volume = 10 | issue = 4 | pages = 725 | date = April 2014 | pmid = 24771084 | pmc = 4023395 | doi = 10.1002/msb.20145228 }}</ref>
The wide occurrence of glycolysis in other species indicates that it is an ancient metabolic pathway.<ref>{{cite journal | vauthors = Romano AH, Conway T | title = Evolution of carbohydrate metabolic pathways | journal = Research in Microbiology | volume = 147 | issue = 6–7 | pages = 448–455 | year = 1996 | pmid = 9084754 | doi = 10.1016/0923-2508(96)83998-2 | doi-access = free }}</ref> Indeed, the reactions that make up glycolysis and its parallel pathway, the [[pentose phosphate pathway]], can occur in the [[Great Oxygenation Event|oxygen-free conditions]] of the [[Archean]] oceans, also in the absence of enzymes, catalyzed by metal ions, meaning this is a plausible prebiotic pathway for [[abiogenesis]].<ref>{{cite journal | vauthors = Keller MA, Turchyn AV, Ralser M | title = Non-enzymatic glycolysis and pentose phosphate pathway-like reactions in a plausible Archean ocean | journal = Molecular Systems Biology | volume = 10 | issue = 4 | article-number = 725 | date = April 2014 | pmid = 24771084 | pmc = 4023395 | doi = 10.1002/msb.20145228 }}</ref>


The most common type of glycolysis is the ''Embden–Meyerhof–Parnas (EMP) pathway'', which was discovered by [[Gustav Embden]], [[Otto Meyerhof]], and [[Jakub Karol Parnas]]. Glycolysis also refers to other pathways, such as the ''[[Entner–Doudoroff pathway]]'' and various heterofermentative and homofermentative pathways. However, the discussion here will be limited to the Embden–Meyerhof–Parnas pathway.<ref>Kim BH, [[Geoffrey Michael Gadd|Gadd GM]]. (2011) Bacterial Physiology and Metabolism, 3rd edition.</ref>
The most common type of glycolysis is the ''Embden–Meyerhof–Parnas (EMP) pathway'', which was discovered by [[Gustav Embden]], [[Otto Meyerhof]], and [[Jakub Karol Parnas]]. Glycolysis also refers to other pathways, such as the ''[[Entner–Doudoroff pathway]]'' and various heterofermentative and homofermentative pathways. However, the discussion here will be limited to the Embden–Meyerhof–Parnas pathway.<ref>Kim BH, [[Geoffrey Michael Gadd|Gadd GM]]. (2011) Bacterial Physiology and Metabolism, 3rd edition.</ref>
Line 14: Line 14:


== Overview ==
== Overview ==
The overall reaction of glycolysis is:
The overall reaction for glycolysis is:
<div style="display:flex; flex-flow:row wrap; border:1px solid #a79c83; margin:1em">
<div style="display:flex; flex-flow:row wrap; border:1px solid #a79c83; margin:1em">
{{Biochem reaction subunit|compound={{sm|d}}-Glucose|link=Glucose|image=D-glucose wpmp.svg|class=skin-invert-image}}
{{Biochem reaction subunit|compound={{sm|d}}-Glucose|link=Glucose|image=D-glucose wpmp.svg|class=skin-invert-image}}
Line 26: Line 26:
* Each liberates an oxygen atom when it binds to an [[adenosine diphosphate]] (ADP) molecule, contributing 2{{nbsp}}O overall
* Each liberates an oxygen atom when it binds to an [[adenosine diphosphate]] (ADP) molecule, contributing 2{{nbsp}}O overall


Charges are balanced by the difference between ADP and ATP.  In the cellular environment, all three hydroxyl groups of ADP dissociate into −O<sup>−</sup> and H<sup>+</sup>, giving ADP<sup>3−</sup>, and this ion tends to exist in an ionic bond with Mg<sup>2+</sup>, giving ADPMg<sup>−</sup>.  ATP behaves identically except that it has four hydroxyl groups, giving ATPMg<sup>2−</sup>.  When these differences along with the true charges on the two phosphate groups are considered together, the net charges of −4 on each side are balanced.{{citation needed|date=September 2024}}
Charges are balanced by the difference between ADP and ATP.  In the cellular environment, all three hydroxyl groups of ADP dissociate into −O<sup>−</sup> and H<sup>+</sup>, giving ADP<sup>3−</sup>, and this ion tends to exist in an ionic bond with Mg<sup>2+</sup>, giving ADPMg<sup>−</sup>.  ATP behaves identically except that it has four hydroxyl groups, giving ATPMg<sup>3−</sup>.  When these differences along with the true charges on the two phosphate groups are considered together, the net charges of −4 on each side are balanced.{{citation needed|date=September 2024}}


In high-oxygen (aerobic) conditions, eukaryotic cells can continue from glycolysis to metabolise the pyruvate through the [[citric acid cycle]]  or the [[electron transport chain]] to produce significantly more ATP.
In high-oxygen (aerobic) conditions, eukaryotic cells can continue from glycolysis to metabolise the pyruvate through the [[citric acid cycle]]  or the [[electron transport chain]] to produce significantly more ATP.
Line 50: Line 50:
[[Arthur Harden]] and [[William John Young (biochemist)|William Young]] along with Nick Sheppard determined, in a second experiment, that a heat-sensitive high-molecular-weight subcellular fraction (the enzymes) and a heat-insensitive low-molecular-weight cytoplasm fraction (ADP, ATP and NAD<sup>+</sup> and other [[Cofactor (biochemistry)|cofactors]]) are required together for fermentation to proceed. This experiment begun by observing that dialyzed (purified) yeast juice could not ferment or even create a sugar phosphate. This mixture was rescued with the addition of undialyzed yeast extract that had been boiled. Boiling the yeast extract renders all proteins inactive (as it denatures them). The ability of boiled extract plus dialyzed juice to complete fermentation suggests that the cofactors were non-protein in character.<ref name=":1" />
[[Arthur Harden]] and [[William John Young (biochemist)|William Young]] along with Nick Sheppard determined, in a second experiment, that a heat-sensitive high-molecular-weight subcellular fraction (the enzymes) and a heat-insensitive low-molecular-weight cytoplasm fraction (ADP, ATP and NAD<sup>+</sup> and other [[Cofactor (biochemistry)|cofactors]]) are required together for fermentation to proceed. This experiment begun by observing that dialyzed (purified) yeast juice could not ferment or even create a sugar phosphate. This mixture was rescued with the addition of undialyzed yeast extract that had been boiled. Boiling the yeast extract renders all proteins inactive (as it denatures them). The ability of boiled extract plus dialyzed juice to complete fermentation suggests that the cofactors were non-protein in character.<ref name=":1" />
[[File:Otto Fritz Meyerhof.jpg|thumb|Otto Meyerhof, one of the main scientists involved in completing the puzzle of glycolysis]]
[[File:Otto Fritz Meyerhof.jpg|thumb|Otto Meyerhof, one of the main scientists involved in completing the puzzle of glycolysis]]
In the 1920s [[Otto Fritz Meyerhof|Otto Meyerhof]] was able to link together some of the many individual pieces of glycolysis discovered by Buchner, Harden, and Young. Meyerhof and his team were able to extract different glycolytic enzymes from [[muscle tissue]], and combine them to artificially create the pathway from glycogen to lactic acid.<ref>{{cite web |title=Otto Meyerhof – Biographical |url=https://www.nobelprize.org/nobel_prizes/medicine/laureates/1922/meyerhof-bio.html |website=www.nobelprize.org |access-date=2016-02-23}}</ref><ref name=":0">{{cite journal | vauthors = Kresge N, Simoni RD, Hill RL | title = Otto Fritz Meyerhof and the elucidation of the glycolytic pathway | journal = The Journal of Biological Chemistry | volume = 280 | issue = 4 | pages = e3 | date = January 2005 | pmid = 15665335 | doi = 10.1016/S0021-9258(20)76366-0 | doi-access = free }}</ref>
In the 1920s [[Otto Fritz Meyerhof|Otto Meyerhof]] was able to link together some of the many individual pieces of glycolysis discovered by Buchner, Harden, and Young. Meyerhof and his team were able to extract distinct glycolytic enzymes from [[muscle tissue]], and combine them to artificially create the pathway from glycogen to lactic acid.<ref>{{cite web |title=Otto Meyerhof – Biographical |url=https://www.nobelprize.org/nobel_prizes/medicine/laureates/1922/meyerhof-bio.html |website=www.nobelprize.org |access-date=2016-02-23}}</ref><ref name=":0">{{cite journal | vauthors = Kresge N, Simoni RD, Hill RL | title = Otto Fritz Meyerhof and the elucidation of the glycolytic pathway | journal = The Journal of Biological Chemistry | volume = 280 | issue = 4 | pages = e3 | date = January 2005 | pmid = 15665335 | doi = 10.1016/S0021-9258(20)76366-0 | doi-access = free }}</ref>


In one paper, Meyerhof and scientist Renate Junowicz-Kockolaty investigated the reaction that splits fructose 1,6-diphosphate into the two triose phosphates. Previous work proposed that the split occurred via 1,3-diphosphoglyceraldehyde plus an oxidizing enzyme and cozymase. Meyerhoff and Junowicz found that the equilibrium constant for the isomerase and aldoses reaction were not affected by inorganic phosphates or any other cozymase or oxidizing enzymes. They further removed diphosphoglyceraldehyde as a possible intermediate in glycolysis.<ref name=":0" />
In one paper, Meyerhof and scientist Renate Junowicz-Kockolaty investigated the reaction that splits fructose 1,6-diphosphate into the two triose phosphates. Previous work proposed that the split occurred via 1,3-diphosphoglyceraldehyde plus an oxidizing enzyme and cozymase. Meyerhoff and Junowicz found that the equilibrium constant for the isomerase and aldoses reaction were not affected by inorganic phosphates or any other cozymase or oxidizing enzymes. They further removed diphosphoglyceraldehyde as a possible intermediate in glycolysis.<ref name=":0" />
Line 64: Line 64:
===Preparatory phase===<!-- This section is linked from [[Cellular respiration]] -->
===Preparatory phase===<!-- This section is linked from [[Cellular respiration]] -->


The first five steps of Glycolysis are regarded as the preparatory (or investment) phase, since they consume energy to convert the glucose into two three-carbon sugar phosphates<ref name="glycolysis_animation"/> ([[glyceraldehyde 3-phosphate|G3P]]).
The first five steps of glycolysis are regarded as the preparatory (or investment) phase, since they consume energy to convert the glucose into two three-carbon sugar phosphates<ref name="glycolysis_animation"/> ([[glyceraldehyde 3-phosphate|G3P]]).
<div>
<div>
{{Stack|margin=yes|{{Enzymatic Reaction
{{Stack|margin=yes|{{Enzymatic Reaction
Line 82: Line 82:
Once glucose enters the cell, the first step is phosphorylation of glucose by a family of enzymes called [[hexokinase]]s to form glucose 6-phosphate (G6P). This reaction consumes ATP, but it acts to keep the glucose concentration inside the cell low, promoting continuous transport of blood glucose into the cell through the plasma membrane transporters. In addition, phosphorylation blocks the glucose from leaking out – the cell lacks transporters for G6P, and free diffusion out of the cell is prevented due to the charged nature of G6P. Glucose may alternatively be formed from the [[phosphorolysis]] or [[hydrolysis]] of intracellular starch or glycogen.
Once glucose enters the cell, the first step is phosphorylation of glucose by a family of enzymes called [[hexokinase]]s to form glucose 6-phosphate (G6P). This reaction consumes ATP, but it acts to keep the glucose concentration inside the cell low, promoting continuous transport of blood glucose into the cell through the plasma membrane transporters. In addition, phosphorylation blocks the glucose from leaking out – the cell lacks transporters for G6P, and free diffusion out of the cell is prevented due to the charged nature of G6P. Glucose may alternatively be formed from the [[phosphorolysis]] or [[hydrolysis]] of intracellular starch or glycogen.


In [[animal]]s, an [[isozyme]] of hexokinase called [[glucokinase]] is also used in the liver, which has a much lower affinity for glucose (K<sub>m</sub> in the vicinity of normal glycemia), and differs in regulatory properties. The different substrate affinity and alternate regulation of this enzyme are a reflection of the role of the liver in maintaining blood sugar levels.
In [[animal]]s, an [[isozyme]] of hexokinase called [[glucokinase]] is also used in the liver, which has a much lower affinity for glucose (K<sub>m</sub> in the vicinity of normal glycemia), and differs in regulatory properties. The various substrate affinities and regulation of this enzyme reflect the role of the liver in maintaining blood sugar levels.


''Cofactors:'' Mg<sup>2+</sup>
''Cofactors:'' Mg<sup>2+</sup>
Line 120: Line 120:
}}}}
}}}}


The energy expenditure of another ATP in this step is justified in 2 ways: The glycolytic process (up to this step) becomes irreversible, and the energy supplied destabilizes the molecule. Because the reaction catalyzed by [[phosphofructokinase 1]] (PFK-1) is coupled to the hydrolysis of ATP (an energetically favorable step) it is, in essence, irreversible, and a different pathway must be used to do the reverse conversion during [[gluconeogenesis]]. This makes the reaction a key regulatory point (see below).
The energy expenditure of another ATP in this step is justified in 2 ways: The glycolytic process (up to this step) becomes irreversible, and the energy supplied destabilizes the molecule. Because the reaction catalyzed by [[phosphofructokinase 1]] (PFK-1) is coupled to the hydrolysis of ATP (an energetically favorable step) it is, in essence, irreversible, and a distinct pathway must be used to do the reverse conversion during [[gluconeogenesis]]. This makes the reaction a key regulatory point (see below).


Furthermore, the second phosphorylation event is necessary to allow the formation of two charged groups (rather than only one) in the subsequent step of glycolysis, ensuring the prevention of free diffusion of substrates out of the cell.
Furthermore, the second phosphorylation event is necessary to allow the formation of two charged groups (rather than only one) in the subsequent step of glycolysis, ensuring the prevention of free diffusion of substrates out of the cell.
Line 149: Line 149:
|minor_reverse_substrate(s)=
|minor_reverse_substrate(s)=
}}}}
}}}}
Destabilizing the molecule in the previous reaction allows the hexose ring to be split by [[Fructose-bisphosphate aldolase|aldolase]] into two triose sugars: [[dihydroxyacetone phosphate]] (a ketose), and [[glyceraldehyde 3-phosphate]] (an aldose). There are two classes of aldolases: class I aldolases, present in animals and plants, and class II aldolases, present in fungi and bacteria; the two classes use different mechanisms in cleaving the ketose ring.
Destabilizing the molecule in the previous reaction allows the hexose ring to be split by [[Fructose-bisphosphate aldolase|aldolase]] into two triose sugars: [[dihydroxyacetone phosphate]] (a ketose), and [[glyceraldehyde 3-phosphate]] (an aldose). Two classes of aldolases exist: class I aldolases, present in animals and plants, and class II aldolases, present in fungi and bacteria. The two classes use distinct mechanisms in cleaving the ketose ring.


Electrons delocalized in the carbon-carbon bond cleavage associate with the alcohol group.  The resulting carbanion is stabilized by the structure of the carbanion itself via resonance charge distribution and by the presence of a charged ion prosthetic group.
Electrons delocalized in the carbon-carbon bond cleavage associate with the alcohol group.  The resulting carbanion is stabilized by resonance and by a positively charged prosthetic group.
{{clear}}{{hr}}
<div>
<div>
{{Stack|margin=yes|{{Enzymatic Reaction
{{Stack|margin=yes|{{Enzymatic Reaction
Line 194: Line 193:
The hydrogen is used to reduce two molecules of [[NAD+|NAD<sup>+</sup>]], a hydrogen carrier, to give NADH '''+''' H<sup>+</sup> for each triose.
The hydrogen is used to reduce two molecules of [[NAD+|NAD<sup>+</sup>]], a hydrogen carrier, to give NADH '''+''' H<sup>+</sup> for each triose.


Hydrogen atom balance and charge balance are both maintained because the phosphate (P<sub>i</sub>) group actually exists in the form of a [[Phosphoric acid#Orthophosphoric acid chemistry|hydrogen phosphate]] anion ({{chem2|HPO4(2−)}}),<ref name="ImportanceBalance" /> which dissociates to contribute the extra H<sup>+</sup> ion and gives a net charge of −3 on both sides.
Hydrogen atom and ion balance and charge balance are both maintained because the phosphate (P<sub>i</sub>) group actually exists in the form of a [[Phosphoric acid#Orthophosphoric acid chemistry|hydrogen phosphate]] anion ({{chem2|HPO4(2−)}}),<ref name="ImportanceBalance" /> which dissociates to contribute the extra H<sup>+</sup> ion and gives a net charge of −3 on both sides.


Here, [[arsenate]] ({{chem2|[AsO4](3-)}}), an anion akin to inorganic phosphate may replace phosphate as a substrate to form 1-arseno-3-phosphoglycerate. This, however, is unstable and readily hydrolyzes to form [[3-Phosphoglycerate|3-phosphoglycerate]], the intermediate in the next step of the pathway. As a consequence of bypassing this step, the molecule of ATP generated from [[1,3-Bisphosphoglycerate|1–3 bisphosphoglycerate]] in the next reaction will not be made, even though the reaction proceeds. As a result, arsenate is an uncoupler of glycolysis.<ref name = "Garrett_2012">{{Cite book|title=Biochemistry| vauthors = Garrett RH, Grisham CM |publisher=Cengage Learning | edition = 5th |year=2012|isbn=978-1-133-10629-6}}</ref>
Here, [[arsenate]] ({{chem2|[AsO4](3-)}}), an anion akin to inorganic phosphate may replace phosphate as a substrate to form 1-arseno-3-phosphoglycerate. This, however, is unstable and readily hydrolyzes to form [[3-Phosphoglycerate|3-phosphoglycerate]], the intermediate in the next step of the pathway. As a consequence of bypassing this step, the molecule of ATP generated from [[1,3-Bisphosphoglycerate|1–3 bisphosphoglycerate]] in the next reaction will not be made, even though the reaction proceeds. As a result, arsenate is an uncoupler of glycolysis.<ref name = "Garrett_2012">{{Cite book|title=Biochemistry| vauthors = Garrett RH, Grisham CM |publisher=Cengage Learning | edition = 5th |year=2012|isbn=978-1-133-10629-6}}</ref>
Line 400: Line 399:


== Regulation ==
== Regulation ==
The enzymes that catalyse glycolysis are regulated via a range of biological mechanisms in order to control overall [[Flux (metabolism)|flux]] though the pathway. This is vital for both [[Homeostasis|homeostatsis]] in a static environment, and [[metabolic adaptation]] to a changing environment or need.<ref>{{cite journal | vauthors = Shimizu K, Matsuoka Y | title = Regulation of glycolytic flux and overflow metabolism depending on the source of energy generation for energy demand | journal = Biotechnology Advances | volume = 37 | issue = 2 | pages = 284–305 | date = March 2019 | pmid = 30576718 | doi = 10.1016/j.biotechadv.2018.12.007 | s2cid = 58591361 }}</ref> The details of regulation for some enzymes are highly conserved between species, whereas others vary widely.<ref name=":3">{{cite journal | vauthors = Chubukov V, Gerosa L, Kochanowski K, Sauer U | title = Coordination of microbial metabolism | journal = Nature Reviews. Microbiology | volume = 12 | issue = 5 | pages = 327–340 | date = May 2014 | pmid = 24658329 | doi = 10.1038/nrmicro3238 | s2cid = 28413431 }}</ref><ref>{{cite book | vauthors = Hochachka PW | title = Hypoxia | chapter = Cross-Species Studies of Glycolytic Function | series = Advances in Experimental Medicine and Biology | volume = 474 | pages = 219–229 | date = 1999 | pmid = 10635004 | doi = 10.1007/978-1-4615-4711-2_18 | publisher = Springer US | isbn = 978-1-4613-7134-2 | veditors = Roach RC, Wagner PD, Hackett PH | place = Boston, MA }}</ref>
The enzymes that catalyse glycolysis are regulated via a range of biological mechanisms in order to control overall [[Flux (metabolism)|flux]] through the pathway. This is vital for both [[homeostasis]] in a static environment, and [[metabolic adaptation]] to a changing environment or need.<ref>{{cite journal | vauthors = Shimizu K, Matsuoka Y | title = Regulation of glycolytic flux and overflow metabolism depending on the source of energy generation for energy demand | journal = Biotechnology Advances | volume = 37 | issue = 2 | pages = 284–305 | date = March 2019 | pmid = 30576718 | doi = 10.1016/j.biotechadv.2018.12.007 | s2cid = 58591361 }}</ref> The details of regulation for some enzymes are highly conserved between species, whereas others vary widely.<ref name=":3">{{cite journal | vauthors = Chubukov V, Gerosa L, Kochanowski K, Sauer U | title = Coordination of microbial metabolism | journal = Nature Reviews. Microbiology | volume = 12 | issue = 5 | pages = 327–340 | date = May 2014 | pmid = 24658329 | doi = 10.1038/nrmicro3238 | s2cid = 28413431 }}</ref><ref>{{cite book | vauthors = Hochachka PW | title = Hypoxia | chapter = Cross-Species Studies of Glycolytic Function | series = Advances in Experimental Medicine and Biology | volume = 474 | pages = 219–229 | date = 1999 | pmid = 10635004 | doi = 10.1007/978-1-4615-4711-2_18 | publisher = Springer US | isbn = 978-1-4613-7134-2 | veditors = Roach RC, Wagner PD, Hackett PH | place = Boston, MA }}</ref>


# Gene Expression: Firstly, the cellular concentrations of glycolytic enzymes are modulated via [[regulation of gene expression]] via [[transcription factors]],<ref>{{cite journal | vauthors = Lemaigre FP, Rousseau GG | title = Transcriptional control of genes that regulate glycolysis and gluconeogenesis in adult liver | journal = The Biochemical Journal | volume = 303 | issue = 1 | pages = 1–14 | date = October 1994 | pmid = 7945228 | pmc = 1137548 | doi = 10.1042/bj3030001 }}</ref> with several glycolysis enzymes themselves acting as [[Protein kinase|regulatory protein kinases]] in the nucleus.<ref>{{cite journal | vauthors = Bian X, Jiang H, Meng Y, Li YP, Fang J, Lu Z | title = Regulation of gene expression by glycolytic and gluconeogenic enzymes | journal = Trends in Cell Biology | pages = 786–799 | date = March 2022 | volume = 32 | issue = 9 | pmid = 35300892 | doi = 10.1016/j.tcb.2022.02.003 | s2cid = 247459973 | doi-access = free }}</ref>
# Gene Expression: Firstly, the cellular concentrations of glycolytic enzymes are modulated via [[regulation of gene expression]] via [[transcription factors]],<ref>{{cite journal | vauthors = Lemaigre FP, Rousseau GG | title = Transcriptional control of genes that regulate glycolysis and gluconeogenesis in adult liver | journal = The Biochemical Journal | volume = 303 | issue = 1 | pages = 1–14 | date = October 1994 | pmid = 7945228 | pmc = 1137548 | doi = 10.1042/bj3030001 }}</ref> with several glycolysis enzymes themselves acting as [[Protein kinase|regulatory protein kinases]] in the nucleus.<ref>{{cite journal | vauthors = Bian X, Jiang H, Meng Y, Li YP, Fang J, Lu Z | title = Regulation of gene expression by glycolytic and gluconeogenic enzymes | journal = Trends in Cell Biology | pages = 786–799 | date = March 2022 | volume = 32 | issue = 9 | pmid = 35300892 | doi = 10.1016/j.tcb.2022.02.003 | s2cid = 247459973 | doi-access = free }}</ref>
Line 415: Line 414:
The three [[enzymes#Control of activity|regulatory enzymes]] are [[hexokinase]] (or [[glucokinase]] in the liver), [[phosphofructokinase 1|phosphofructokinase]], and [[pyruvate kinase]]. The [[flux (biochemistry)|flux]] through the glycolytic pathway is adjusted in response to conditions both inside and outside the cell. The internal factors that  regulate glycolysis do so primarily to provide [[adenosine triphosphate|ATP]] in adequate quantities for the cell's needs. The external factors act primarily on the [[liver]], [[Adipose tissue|fat tissue]], and [[muscle]]s, which can remove large quantities of glucose from the blood after meals (thus preventing [[hyperglycemia]] by storing the excess glucose as fat or glycogen, depending on the tissue type). The liver is also capable of releasing glucose into the blood between meals, during fasting, and exercise thus preventing [[hypoglycemia]] by means of [[glycogenolysis]] and [[gluconeogenesis]]. These latter reactions coincide with the halting of glycolysis in the liver.
The three [[enzymes#Control of activity|regulatory enzymes]] are [[hexokinase]] (or [[glucokinase]] in the liver), [[phosphofructokinase 1|phosphofructokinase]], and [[pyruvate kinase]]. The [[flux (biochemistry)|flux]] through the glycolytic pathway is adjusted in response to conditions both inside and outside the cell. The internal factors that  regulate glycolysis do so primarily to provide [[adenosine triphosphate|ATP]] in adequate quantities for the cell's needs. The external factors act primarily on the [[liver]], [[Adipose tissue|fat tissue]], and [[muscle]]s, which can remove large quantities of glucose from the blood after meals (thus preventing [[hyperglycemia]] by storing the excess glucose as fat or glycogen, depending on the tissue type). The liver is also capable of releasing glucose into the blood between meals, during fasting, and exercise thus preventing [[hypoglycemia]] by means of [[glycogenolysis]] and [[gluconeogenesis]]. These latter reactions coincide with the halting of glycolysis in the liver.


In addition hexokinase and [[glucokinase]] act independently of the hormonal effects as controls at the entry points of glucose into the cells of different tissues.  Hexokinase responds to the [[glucose-6-phosphate]] (G6P) level in the cell, or, in the case of glucokinase, to the blood sugar level in the blood to impart entirely intracellular controls of the glycolytic pathway in different tissues (see [[#Hexokinase and glucokinase|below]]).<ref name="stryer" />
In addition hexokinase and [[glucokinase]] act independently of the hormonal effects as controls at the entry points of glucose into the cells of distinct tissues.  Hexokinase responds to the [[glucose-6-phosphate]] (G6P) level in the cell, or, in the case of glucokinase, to the blood sugar level in the blood to impart entirely intracellular controls of the glycolytic pathway in distinct tissues (see [[#Hexokinase and glucokinase|below]]).<ref name="stryer" />


When glucose has been converted into G6P by hexokinase or glucokinase, it can either be converted to [[glucose-1-phosphate]] (G1P) for conversion to [[glycogen]], or it is alternatively converted by glycolysis to [[Pyruvic acid|pyruvate]], which enters the [[mitochondrion]] where it is converted into [[acetyl-CoA]] and then into [[citrate]]. Excess [[citrate]] is exported from the mitochondrion back into the cytosol, where [[ATP citrate lyase]] regenerates [[acetyl-CoA]] and [[oxaloacetic acid|oxaloacetate]] (OAA). The acetyl-CoA is then used for [[fatty acid synthesis]] and [[Cholesterol|cholesterol synthesis]], two important ways of utilizing excess glucose when its concentration is high in blood. The regulated enzymes catalyzing these reactions perform these functions when they have been dephosphorylated through the action of insulin on the liver cells.  Between meals, during [[fasting]], [[Physical exercise|exercise]] or hypoglycemia, glucagon and epinephrine are released into the blood. This causes liver glycogen to be converted back to G6P, and then converted to glucose by the liver-specific enzyme [[glucose 6-phosphatase]] and released into the blood. Glucagon and epinephrine also stimulate gluconeogenesis, which converts non-carbohydrate substrates into G6P, which joins the G6P derived from glycogen, or substitutes for it when the liver glycogen store have been depleted. This is critical for brain function, since the brain utilizes glucose as an energy source under most conditions.<ref name=stryer8>{{cite book | vauthors = Stryer L | title=Biochemistry. |edition= Fourth |location= New York |publisher= W.H. Freeman and Company|date= 1995 |pages= 773|isbn= 0-7167-2009-4 }}</ref> The simultaneously phosphorylation of, particularly, [[phosphofructokinase]], but also, to a certain extent pyruvate kinase, prevents glycolysis occurring at the same time as gluconeogenesis and glycogenolysis.
When glucose has been converted into G6P by hexokinase or glucokinase, it can either be converted to [[glucose-1-phosphate]] (G1P) for conversion to [[glycogen]], or it is alternatively converted by glycolysis to [[Pyruvic acid|pyruvate]], which enters the [[mitochondrion]] where it is converted into [[acetyl-CoA]] and then into [[citrate]]. Excess [[citrate]] is exported from the mitochondrion back into the cytosol, where [[ATP citrate lyase]] regenerates [[acetyl-CoA]] and [[oxaloacetic acid|oxaloacetate]] (OAA). The acetyl-CoA is then used for [[fatty acid synthesis]] and [[Cholesterol|cholesterol synthesis]], two important ways of utilizing excess glucose when its concentration is high in blood. The regulated enzymes catalyzing these reactions perform these functions when they have been dephosphorylated through the action of insulin on the liver cells.  Between meals, during [[fasting]], [[Physical exercise|exercise]] or hypoglycemia, glucagon and epinephrine are released into the blood. This causes liver glycogen to be converted back to G6P, and then converted to glucose by the liver-specific enzyme [[glucose 6-phosphatase]] and released into the blood. Glucagon and epinephrine also stimulate gluconeogenesis, which converts non-carbohydrate substrates into G6P, which joins the G6P derived from glycogen, or substitutes for it when the liver glycogen store have been depleted. This is critical for brain function, since the brain utilizes glucose as an energy source under most conditions.<ref name=stryer8>{{cite book | vauthors = Stryer L | title=Biochemistry. |edition= Fourth |location= New York |publisher= W.H. Freeman and Company|date= 1995 |pages= 773|isbn= 0-7167-2009-4 }}</ref> The simultaneously phosphorylation of, particularly, [[phosphofructokinase]], but also, to a certain extent pyruvate kinase, prevents glycolysis occurring at the same time as gluconeogenesis and glycogenolysis.
Line 435: Line 434:
[[Citrate]] inhibits phosphofructokinase when tested ''in vitro'' by enhancing the inhibitory effect of ATP. However, it is doubtful that this is a meaningful effect ''in vivo'', because citrate in the cytosol is utilized mainly for conversion to [[acetyl-CoA]] for [[fatty acid]] and [[cholesterol]] synthesis.
[[Citrate]] inhibits phosphofructokinase when tested ''in vitro'' by enhancing the inhibitory effect of ATP. However, it is doubtful that this is a meaningful effect ''in vivo'', because citrate in the cytosol is utilized mainly for conversion to [[acetyl-CoA]] for [[fatty acid]] and [[cholesterol]] synthesis.


[[TP53-inducible glycolysis and apoptosis regulator|TIGAR]], a p53 induced enzyme, is responsible for the regulation of [[phosphofructokinase 1|phosphofructokinase]] and acts to protect against oxidative stress.<ref>{{Cite book|title=TIGAR| vauthors = Lackie J |publisher=Oxford University Press|year=2010|isbn=978-0-19-954935-1|location=Oxford Reference Online}}</ref> TIGAR is a single enzyme with dual function that regulates F2,6BP. It can behave as a phosphatase (fructuose-2,6-bisphosphatase) which cleaves the phosphate at carbon-2 producing F6P. It can also behave as a kinase (PFK2) adding a phosphate onto carbon-2 of F6P which produces F2,6BP. In humans, the TIGAR protein is encoded by ''C12orf5'' gene. The TIGAR enzyme will hinder the forward progression of glycolysis, by creating a build up of fructose-6-phosphate (F6P) which is isomerized into glucose-6-phosphate (G6P). The accumulation of G6P will shunt carbons into the pentose phosphate pathway.<ref>{{cite journal | vauthors = Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R, Gottlieb E, Vousden KH | title = TIGAR, a p53-inducible regulator of glycolysis and apoptosis | journal = Cell | volume = 126 | issue = 1 | pages = 107–120 | date = July 2006 | pmid = 16839880 | doi = 10.1016/j.cell.2006.05.036 | s2cid = 15006256 | doi-access = free }}</ref><ref>{{Cite web|url=https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=ShowDetailView&TermToSearch=57103|title=TIGAR TP53 induced glycolysis regulatory phosphatase [Homo sapiens (human)] – Gene – NCBI|website=www.ncbi.nlm.nih.gov|access-date=2018-05-17}}</ref>
[[TP53-inducible glycolysis and apoptosis regulator|TIGAR]], a p53 induced enzyme, is responsible for the regulation of [[phosphofructokinase 1|phosphofructokinase]] and acts to protect against oxidative stress.<ref>{{Cite book|title=TIGAR| vauthors = Lackie J |publisher=Oxford University Press|year=2010|isbn=978-0-19-954935-1|location=Oxford Reference Online}}</ref> TIGAR is a single enzyme with dual function that regulates F2,6BP. It can behave as a phosphatase (fructuose-2,6-bisphosphatase) which cleaves the phosphate at carbon-2 producing F6P. It can also behave as a kinase (PFK2) adding a phosphate onto carbon-2 of F6P which produces F2,6BP. In humans, the TIGAR protein is encoded by ''C12orf5'' gene. The TIGAR enzyme will hinder the forward progression of glycolysis, by creating a build up of fructose-6-phosphate (F6P) which is isomerized into glucose-6-phosphate (G6P). The accumulation of G6P will shunt carbons into the pentose phosphate pathway.<ref>{{cite journal | vauthors = Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R, Gottlieb E, Vousden KH | title = TIGAR, a p53-inducible regulator of glycolysis and apoptosis | journal = Cell | volume = 126 | issue = 1 | pages = 107–120 | date = July 2006 | pmid = 16839880 | doi = 10.1016/j.cell.2006.05.036 | bibcode = 2006Cell..126..107B | s2cid = 15006256 | doi-access = free }}</ref><ref>{{Cite web|url=https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=ShowDetailView&TermToSearch=57103|title=TIGAR TP53 induced glycolysis regulatory phosphatase [Homo sapiens (human)] – Gene – NCBI|website=www.ncbi.nlm.nih.gov|access-date=2018-05-17}}</ref>


==== Pyruvate kinase ====
==== Pyruvate kinase ====
[[File:Pyruvate Kinase 1A3W wpmp.png|thumb|right|[[Yeast]] [[pyruvate kinase]] ({{PDB|1A3W}})]]
[[File:Pyruvate Kinase 1A3W wpmp.png|thumb|right|[[Yeast]] [[pyruvate kinase]] ({{PDB|1A3W}})]]
{{Main|Pyruvate kinase}}
{{Main|Pyruvate kinase}}
The final step of glycolysis is catalysed by pyruvate kinase to form pyruvate and another ATP. It is regulated by a range of different transcriptional, covalent and non-covalent regulation mechanisms, which can vary widely in different tissues.<ref>{{cite journal | vauthors = Carbonell J, Felíu JE, Marco R, Sols A | title = Pyruvate kinase. Classes of regulatory isoenzymes in mammalian tissues | journal = European Journal of Biochemistry | volume = 37 | issue = 1 | pages = 148–156 | date = August 1973 | pmid = 4729424 | doi = 10.1111/j.1432-1033.1973.tb02969.x | hdl = 10261/78345 | hdl-access = free }}</ref><ref>{{cite journal | vauthors = Valentini G, Chiarelli L, Fortin R, Speranza ML, Galizzi A, Mattevi A | title = The allosteric regulation of pyruvate kinase | journal = The Journal of Biological Chemistry | volume = 275 | issue = 24 | pages = 18145–18152 | date = June 2000 | pmid = 10751408 | doi = 10.1074/jbc.m001870200 | doi-access = free }}</ref><ref>{{cite journal | vauthors = Israelsen WJ, Vander Heiden MG | title = Pyruvate kinase: Function, regulation and role in cancer | journal = Seminars in Cell & Developmental Biology | volume = 43 | pages = 43–51 | date = July 2015 | pmid = 26277545 | pmc = 4662905 | doi = 10.1016/j.semcdb.2015.08.004 }}</ref> For example, in the liver, pyruvate kinase is regulated based on glucose availability. During fasting (no glucose available), [[glucagon]] activates [[protein kinase A]] which phosphorylates pyruvate kinase to inhibit it.<ref name=":4">{{cite journal | vauthors = Engström L | title = The regulation of liver pyruvate kinase by phosphorylation—dephosphorylation | journal = Current Topics in Cellular Regulation | volume = 13 | pages = 28–51 | date = 1978 | pmid = 208818 | doi = 10.1016/b978-0-12-152813-3.50006-9 | publisher = Elsevier | isbn = 978-0-12-152813-3 }}</ref> An increase in blood sugar leads to secretion of [[insulin]], which activates [[protein phosphatase 1]], leading to dephosphorylation and re-activation of pyruvate kinase.<ref name=":4" /> These controls prevent pyruvate kinase from being active at the same time as the enzymes that catalyze the reverse reaction ([[pyruvate carboxylase]] and [[phosphoenolpyruvate carboxykinase]]), preventing a [[futile cycle]].<ref name=":4" /> Conversely, the isoform of pyruvate kinasein found in muscle is not affected by protein kinase A (which is activated by adrenaline in that tissue), so that glycolysis remains active in muscles even during fasting.<ref name=":4" />
The final step of glycolysis is catalysed by pyruvate kinase to form pyruvate and another ATP. It is regulated by a range of transcriptional, covalent and non-covalent regulation mechanisms, which can vary widely.<ref>{{cite journal | vauthors = Carbonell J, Felíu JE, Marco R, Sols A | title = Pyruvate kinase. Classes of regulatory isoenzymes in mammalian tissues | journal = European Journal of Biochemistry | volume = 37 | issue = 1 | pages = 148–156 | date = August 1973 | pmid = 4729424 | doi = 10.1111/j.1432-1033.1973.tb02969.x | hdl = 10261/78345 | hdl-access = free }}</ref><ref>{{cite journal | vauthors = Valentini G, Chiarelli L, Fortin R, Speranza ML, Galizzi A, Mattevi A | title = The allosteric regulation of pyruvate kinase | journal = The Journal of Biological Chemistry | volume = 275 | issue = 24 | pages = 18145–18152 | date = June 2000 | pmid = 10751408 | doi = 10.1074/jbc.m001870200 | doi-access = free }}</ref><ref>{{cite journal | vauthors = Israelsen WJ, Vander Heiden MG | title = Pyruvate kinase: Function, regulation and role in cancer | journal = Seminars in Cell & Developmental Biology | volume = 43 | pages = 43–51 | date = July 2015 | pmid = 26277545 | pmc = 4662905 | doi = 10.1016/j.semcdb.2015.08.004 }}</ref> For example, in the liver, pyruvate kinase is regulated based on glucose availability. During fasting (no glucose available), [[glucagon]] activates [[protein kinase A]] which phosphorylates pyruvate kinase to inhibit it.<ref name=":4">{{cite journal | vauthors = Engström L | title = The regulation of liver pyruvate kinase by phosphorylation—dephosphorylation | journal = Current Topics in Cellular Regulation | volume = 13 | pages = 28–51 | date = 1978 | pmid = 208818 | doi = 10.1016/b978-0-12-152813-3.50006-9 | publisher = Elsevier | isbn = 978-0-12-152813-3 }}</ref> An increase in blood sugar leads to secretion of [[insulin]], which activates [[protein phosphatase 1]], leading to dephosphorylation and re-activation of pyruvate kinase.<ref name=":4" /> These controls prevent pyruvate kinase from being active at the same time as the enzymes that catalyze the reverse reaction ([[pyruvate carboxylase]] and [[phosphoenolpyruvate carboxykinase]]), preventing a [[futile cycle]].<ref name=":4" /> Conversely, the isoform of pyruvate kinasein found in muscle is not affected by protein kinase A (which is activated by adrenaline in that tissue), so that glycolysis remains active in muscles even during fasting.<ref name=":4" />


== Post-glycolysis processes ==
== Post-glycolysis processes ==
Line 487: Line 486:


To cataplerotically remove oxaloacetate from the citric cycle, [[malate]] can be transported from the mitochondrion into the cytoplasm, decreasing the amount of oxaloacetate that can be regenerated.<ref name=stryer3 /> Furthermore, citric acid intermediates are [[Citric acid cycle#Citric acid cycle intermediates serve as substrates for biosynthetic processes|constantly used to form a variety of substances such as the purines, pyrimidines and porphyrins]].<ref name=stryer3 />
To cataplerotically remove oxaloacetate from the citric cycle, [[malate]] can be transported from the mitochondrion into the cytoplasm, decreasing the amount of oxaloacetate that can be regenerated.<ref name=stryer3 /> Furthermore, citric acid intermediates are [[Citric acid cycle#Citric acid cycle intermediates serve as substrates for biosynthetic processes|constantly used to form a variety of substances such as the purines, pyrimidines and porphyrins]].<ref name=stryer3 />
===Anaerobic extended glycolysis===
A number of anaerobic eukaryotes have acquired the ability to perform ''extended hydrolysis''. The prototypical example is the [[hydrogenosome]], but there are also transitional {{chem2|H2}}-producing mitochondria with this function. This process requires:<ref name="Novák-2023">{{cite journal | vauthors = Novák LV, Treitli SC, Pyrih J, Hałakuc P, Pipaliya SV, Vacek V, Brzoň O, Soukal P, Eme L, Dacks JB, Karnkowska A, Eliáš M, Hampl V | title = Genomics of Preaxostyla Flagellates Illuminates the Path Towards the Loss of Mitochondria | journal = PLOS Genetics | volume = 19 | issue = 12 | article-number = e1011050 | date = December 2023 | pmid = 38060519 | pmc = 10703272 | doi = 10.1371/journal.pgen.1011050 | doi-access = free | veditors = Dutcher SK }}</ref>
* [[Pyruvate:ferredoxin oxidoreductase]], which converts pyruvate into acetyl-CoA and CO<sub>2</sub> while reducing the [[ferredoxin]].
* [[Hydrogenase]], which converts H<sup>+</sup> into H<sub>2</sub> while oxidizing the ferredoxin.
* [[Acetyl-CoA synthetase]] (in reverse), which converts acetyl-CoA and ADP + Pi into acetate, [[coenzyme A]], and ATP. (A variant of the reaction uses [[Acetate CoA-transferase|acetate:succinate CoA transferase]] and [[succinyl-CoA synthatase]] in reverse.)<ref name=Hjort09>{{cite journal | vauthors = Hjort K, Goldberg AV, Tsaousis AD, Hirt RP, Embley TM | title = Diversity and reductive evolution of mitochondria among microbial eukaryotes | journal = Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences | volume = 365 | issue = 1541 | pages = 713–27 | date = March 2010 | pmid = 20124340 | pmc = 2817227 | doi = 10.1098/rstb.2009.0224 }}</ref>
The net reaction is conversion of singular equivalents of [[pyruvate]], ADP, and Pi into ATP, CO<sub>2</sub>, acetate, and H<sub>2</sub>.<ref name="Novák-2023"/>


== Intermediates for other pathways ==
== Intermediates for other pathways ==
Line 513: Line 520:


=== Genetic diseases ===
=== Genetic diseases ===
Glycolytic mutations are generally rare due to importance of the metabolic pathway; the majority of occurring mutations result in an inability of the cell to respire, and therefore cause the death of the cell at an early stage. However, some mutations ([[glycogen storage disease]]s and other [[inborn errors of carbohydrate metabolism]]) are seen with one notable example being [[pyruvate kinase deficiency]], leading to chronic hemolytic anemia.{{citation needed|date=May 2023}}
Glycolytic mutations are generally rare due to importance of the metabolic pathway; the majority of occurring mutations result in an inability of the cell to respire, and therefore cause the death of the cell at an early stage. However, some mutations ([[glycogen storage disease]]s and other [[inborn errors of carbohydrate metabolism]]) are seen with one notable example being [[pyruvate kinase deficiency]], leading to chronic hemolytic anemia.<ref>{{Cite journal |last1=Luke |first1=Neeti |last2=Hillier |first2=Kirsty |last3=Al-Samkari |first3=Hanny |last4=Grace |first4=Rachael F. |date=2023-05-01 |title=Updates and advances in pyruvate kinase deficiency |journal=Trends in Molecular Medicine |language=English |volume=29 |issue=5 |pages=406–418 |doi=10.1016/j.molmed.2023.02.005 |issn=1471-4914 |pmc=11088755 |pmid=36935283}}</ref>


In [[combined malonic and methylmalonic aciduria]] (CMAMMA) due to [[ACSF3]] deficiency, glycolysis is reduced by −50%, which is caused by reduced [[Post-translational modification#Cofactors for enhanced enzymatic activity|lipoylation]] of mitochondrial enzymes such as the [[pyruvate dehydrogenase complex]] and [[Oxoglutarate dehydrogenase complex|α-ketoglutarate dehydrogenase complex]].<ref>{{Cite journal |last1=Wehbe |first1=Zeinab |last2=Behringer |first2=Sidney |last3=Alatibi |first3=Khaled |last4=Watkins |first4=David |last5=Rosenblatt |first5=David |last6=Spiekerkoetter |first6=Ute |last7=Tucci |first7=Sara |date=2019-11-01 |title=The emerging role of the mitochondrial fatty-acid synthase (mtFASII) in the regulation of energy metabolism |url=https://www.sciencedirect.com/science/article/pii/S1388198119301349 |journal=Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids |volume=1864 |issue=11 |pages=1629–1643 |doi=10.1016/j.bbalip.2019.07.012 |pmid=31376476 |issn=1388-1981|url-access=subscription }}</ref>
In [[combined malonic and methylmalonic aciduria]] (CMAMMA) due to [[ACSF3]] deficiency, glycolysis is reduced by −50%, which is caused by reduced [[Post-translational modification#Cofactors for enhanced enzymatic activity|lipoylation]] of mitochondrial enzymes such as the [[pyruvate dehydrogenase complex]] and [[Oxoglutarate dehydrogenase complex|α-ketoglutarate dehydrogenase complex]].<ref>{{Cite journal |last1=Wehbe |first1=Zeinab |last2=Behringer |first2=Sidney |last3=Alatibi |first3=Khaled |last4=Watkins |first4=David |last5=Rosenblatt |first5=David |last6=Spiekerkoetter |first6=Ute |last7=Tucci |first7=Sara |date=2019-11-01 |title=The emerging role of the mitochondrial fatty-acid synthase (mtFASII) in the regulation of energy metabolism |url=https://www.sciencedirect.com/science/article/pii/S1388198119301349 |journal=Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids |volume=1864 |issue=11 |pages=1629–1643 |doi=10.1016/j.bbalip.2019.07.012 |pmid=31376476 |issn=1388-1981|url-access=subscription }}</ref>
Line 526: Line 533:


==Interactive pathway map==
==Interactive pathway map==
The diagram below shows human protein names. Names in other organisms may be different and the number of [[isozyme]]s (such as HK1, HK2, ...) is likely to be different too.
The diagram below shows human protein names. Names in other organisms may differ, and the numbers of [[isozyme]]s (such as HK1, HK2, ...) likely differ also.


{{GlycolysisGluconeogenesis_WP534}}
{{GlycolysisGluconeogenesis_WP534}}
Line 612: Line 619:
{{wide image|Glycolysis--F-PM.png|1430px|Glycolysis - Structure of anaerobic glycolysis components showed using Fischer projections, left, and polygonal model, right. The compounds correspond to glucose (GLU),  glucose 6-phosphate (G6P), fructose 6-phosphate (F6P), fructose 1,6-bisphosphate ( F16BP), dihydroxyacetone phosphate (DHAP), glyceraldehyde 3-phosphate(GA3P), 1,3-bisphosphoglycerate (13BPG), 3-phosphoglycerate (3PG), 2-phosphoglycerate (2PG), phosphoenolpyruvate (PEP), pyruvate (PIR), and lactate (LAC). The enzymes which participate of this pathway are indicated by underlined numbers, and correspond to hexokinase (<u>1</u>), glucose-6-phosphate isomerase (<u>2</u>), phosphofructokinase-1 (<u>3</u>), fructose-bisphosphate aldolase (<u>4</u>), triosephosphate isomerase (<u>5</u>), glyceraldehyde-3-phosphate dehydrogenase (<u>5</u>),  phosphoglycerate kinase (<u>7</u>), phosphoglycerate mutase (<u>8</u>), phosphopyruvate hydratase (enolase) (<u>9</u>), pyruvate kinase (<u>10</u>), and lactate dehydrogenase (<u>11</u>). The participant coenzymes (NAD<sup>+</sup>, NADH + H<sup>+</sup>, ATP and ADP), inorganic phosphate, {{chem2|H2O}} and {{chem2|CO2}} were omitted in these representations. The phosphorylation reactions from ATP, as well the ADP phosphorylation reactions in later steps of glycolysis are shown as ~P respectively entering or going out the pathway. The oxireduction reactions using NAD<sup>+</sup> or NADH are observed as hydrogens "2H" going out or entering the pathway.}}
{{wide image|Glycolysis--F-PM.png|1430px|Glycolysis - Structure of anaerobic glycolysis components showed using Fischer projections, left, and polygonal model, right. The compounds correspond to glucose (GLU),  glucose 6-phosphate (G6P), fructose 6-phosphate (F6P), fructose 1,6-bisphosphate ( F16BP), dihydroxyacetone phosphate (DHAP), glyceraldehyde 3-phosphate(GA3P), 1,3-bisphosphoglycerate (13BPG), 3-phosphoglycerate (3PG), 2-phosphoglycerate (2PG), phosphoenolpyruvate (PEP), pyruvate (PIR), and lactate (LAC). The enzymes which participate of this pathway are indicated by underlined numbers, and correspond to hexokinase (<u>1</u>), glucose-6-phosphate isomerase (<u>2</u>), phosphofructokinase-1 (<u>3</u>), fructose-bisphosphate aldolase (<u>4</u>), triosephosphate isomerase (<u>5</u>), glyceraldehyde-3-phosphate dehydrogenase (<u>5</u>),  phosphoglycerate kinase (<u>7</u>), phosphoglycerate mutase (<u>8</u>), phosphopyruvate hydratase (enolase) (<u>9</u>), pyruvate kinase (<u>10</u>), and lactate dehydrogenase (<u>11</u>). The participant coenzymes (NAD<sup>+</sup>, NADH + H<sup>+</sup>, ATP and ADP), inorganic phosphate, {{chem2|H2O}} and {{chem2|CO2}} were omitted in these representations. The phosphorylation reactions from ATP, as well the ADP phosphorylation reactions in later steps of glycolysis are shown as ~P respectively entering or going out the pathway. The oxireduction reactions using NAD<sup>+</sup> or NADH are observed as hydrogens "2H" going out or entering the pathway.}}
</div>
</div>
== Structure of glycolysis components in skeletal diagram and conservation-of-matter model ==
[[File:Glycolysis skeletal diagram.png|thumb|1200px|The Glycolysis pathway diagram illustrates the metabolic reactions that allow for the breakdown of glucose into pyruvate, often as preparation for further catabolic reactions.]]
The intermediates of glycolysis depicted in skeletal diagram show the chemical structures changing step by step, with cofactors such as NADH, ATP, and water and phosphates to balance reactions' stoichiometry. Each enzyme that mediates each reaction is indicated in the reversible arrow model of chemical reactions, as most enzymes catalyze bidirectional chemical reactions. Duplicates, such as the reversible re-arrangement between dihydroxyacetone and glyceraldehyde on the bottom row of reactions, represent two moles of C3 fragments derived from a single mole of the preceding C6 fragment of fructose bisphosphate, giving a net of two ATP generated. Thus the diagram must be read with rules of stoichiometry and balance-of-matter principles in mind. Follow the green "START" button to the red "END" button to trace the pathway through the structural pathway diagram.


== See also ==
== See also ==
Line 637: Line 648:
* [http://biochemweb.fenteany.com/metabolism.shtml Metabolism, Cellular Respiration and Photosynthesis – The Virtual Library of Biochemistry, Molecular Biology and Cell Biology]
* [http://biochemweb.fenteany.com/metabolism.shtml Metabolism, Cellular Respiration and Photosynthesis – The Virtual Library of Biochemistry, Molecular Biology and Cell Biology]
* [https://web.archive.org/web/20051016004951/http://www2.ufp.pt/~pedros/bq/glycolysis.htm The chemical logic behind glycolysis] at ufp.pt
* [https://web.archive.org/web/20051016004951/http://www2.ufp.pt/~pedros/bq/glycolysis.htm The chemical logic behind glycolysis] at ufp.pt
* [http://www.expasy.org/tools/pathways/boehringer_legends.html Expasy biochemical pathways poster] at [[ExPASy]]
* [http://www.expasy.org/tools/pathways/boehringer_legends.html Expasy biochemical pathways poster] {{Webarchive|url=https://web.archive.org/web/20100620103305/http://www.expasy.org/tools/pathways/boehringer_legends.html |date=2010-06-20 }} at [[ExPASy]]
* {{MedicalMnemonics|317|5468}}
* {{MedicalMnemonics|317|5468}}
* [http://www.metpath.teithe.gr/?lang=en&part=glycolysis ''metpath'': Interactive representation of glycolysis]
* [http://www.metpath.teithe.gr/?lang=en&part=glycolysis ''metpath'': Interactive representation of glycolysis] {{Webarchive|url=https://web.archive.org/web/20150402151035/http://www.metpath.teithe.gr/?lang=en&part=glycolysis |date=2015-04-02 }}
{{Library resources box
{{Library resources box
|by=no
|by=no